~~<i id='FB81E23E02'><strike id='FB81E23E02'><tt id='FB81E23E02'><pre id='FB81E23E02'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：explore 2025-09-29 21:26:33 - browse：19

In the dark, fingers hover over a phone with text exchange displayed on its screen — Adobe

Early this spring, dozens of volunteers fielding requests from people struggling with eating disorders — many of whom call amid mental health crises — received surprising and abrupt news: Their service at the National Eating Disorders Association would end within weeks.

In their place, the nonprofit would offer an AI chatbot called Tessa.

NEDA told volunteers the tool could respond faster and help more people than they could; the helpline was missing almost half of clients’ attempts to contact them, and wait times had surged to several days or even almost two weeks, according to emails reviewed by STAT.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： FDA approves potent Eli Lilly obesity drug, Zepbound

explore

knowledge

explore

hotspot

explore

entertainment

JustinSullivan/GettyImagesFluvaccineappearstobeofferingreasonablelevelsofprotectionthiswinter,withpa

WSS

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

RSV vaccines may be linked to small increased risk of developing GBS

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Change Healthcare cyberattack outage could last weeks

Covid isolation guidance eased by the CDC

White House calls on federal agencies to crack down on AI abuses

knowledge

hotspot

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pfizer highlights cancer drugs it thinks could reignite investor interest

United colonoscopy coverage change 'may cost lives,' doctors say

Removing probiotics from the NICU could threaten preemies' health

Trump demands the U.S. pay no more for drugs than other countries … again

A clever new way to fix Medicaid and graduate medical education

How one medical school became remarkably diverse

Free speech concerns arise in wake of journal editor Eisen's firing

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA approves potent Eli Lilly obesity drug, Zepbound

knowledge

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Medicare solvency divides Republicans at the presidential debate

Will General Catalyst be the first of many hospital takeovers?

Victims of gun violence feel impacts long after bullet wound

FDA does about

Medicare solvency divides Republicans at the presidential debate

explore

hotspot

explore

entertainment